New RBI Grade B 2025 Notification will come Soon! Enroll Here

    Question

    What is the name of the new Covid-19 vaccine approved by

    the U.S. FDA for high-risk groups in 2025?
    A SpikeZero Correct Answer Incorrect Answer
    B mNexspike Correct Answer Incorrect Answer
    C Covishield-R Correct Answer Incorrect Answer
    D Spikevax-2 Correct Answer Incorrect Answer
    E mImmuno Correct Answer Incorrect Answer

    Solution

    The U.S. FDA approved Moderna’s mNexspike, a next-generation Covid-19 vaccine tailored for high-risk individuals.

    Practice Next